Close
Close
Treatment Database
epoprostenol
Trade Name Flolan
Orphan Indication Secondary pulmonary hypertension due to intrinsic precapillary pulmonary vascular disease
USA Market Approval 14-04-2000
USA Designation Date 22-03-1999
Sponsor GlaxoSmithKline
2301 Renaissance Blvd, P. O. Box 61540
King of Prussia, Pennsylvania, 19406
More about Secondary pulmonary hypertension
Free Newsletter
Related Videos
by Abidemi Uruejoma
321 views